100880-61-3Relevant articles and documents
Towards Dual-Functionality Spin-Crossover Complexes
Feltham, Humphrey L. C.,Dankhoff, Katja,Meledandri, Carla J.,Brooker, Sally
, p. 582 - 589 (2018)
The multistep synthesis of a versatile new 4-substituted 3,5-bis(2-pyridyl)-1,2,4-triazole (Rdpt) ligand, 4-[4-(2-aminomethyl)phenyl]-3,5-bis(2-pyridyl)-4 H-1,2,4-triazole (apdpt), is reported, which features a reactive aminomethyl para-substituent on the phenyl group that points “out of the back” of the triazole. This enables further functionalisation under mild conditions by using a range of esters to form an amide link. Specifically, this proof of principle study demonstrates the synthesis of apdpt successfully appended with gold-binding thioctic acid (tpdpt), graphene-binding/emissive pyrene/propylpyrene (prdpt/pbdpt), and a Langmuir–Blodgett film-forming polyethylene glycol (PEG) tail (pgdpt). These ligands are subsequently reacted with [Fe(pyridine)4(NCBH3)2] to give the mononuclear iron(II) complexes [Fe(Rdpt)2(NCBH3)2]?solvent, in which Rdpt/solvent is tpdpt/2.5 H2O (1), prdpt/0.5 CHCl3?H2O (2), and pbdpt/0.5 CHCl3?2 H2O (3), as red powders. Magnetic studies on these powders indicate that the complexes undergo only very gradual and incomplete spin crossover, from completely or mostly high spin at 300 K, to half or three-quarters high spin at 50 K. Gold nanoparticles are successfully functionalised with the thioctic acid tpdpt ligand to give tpdpt@Au with an average diameter (as determined by TEM) of (3.1±0.7) nm. Preliminary studies on the two pyrene systems in dimethylformamide show that upon excitation at λ=345 nm the blue fluorescence observed for the free ligands is retained, essentially unaffected, in the respective complexes.
Thiourea derived troeger's bases as molecular cleft receptors and colorimetric sensors for anions
Boyle, Elaine M.,Comby, Steve,Molloy, Jennifer K.,Gunnlaugsson, Thorfinnur
, p. 8312 - 8319 (2013)
Thiourea-functionalized Troeger's base receptors 1 and 2 have been synthesized and evaluated as novel for the recognition of anions. Receptor 2 gave rise to significant changes in the absorption spectrum upon titration with AcO- and H2/su
Red-shifted tetra-ortho-halo-azobenzenes for photo-regulated transmembrane anion transport
Bo, Zonghua,Duarte, Fernanda,Kerckhoffs, Aidan,Langton, Matthew J.,Penty, Samuel E.
supporting information, p. 9058 - 9067 (2021/11/04)
Photo-responsive synthetic ion transporters are of interest as tools for studying transmembrane transport processes and have potential applications as targeted therapeutics, due to the possibility of spatiotemporal control and wavelength-dependent function. Here we report the synthesis of novel symmetric and non-symmetric red-shifted tetra-ortho-chloro- and tetra-ortho-fluoro azobenzenes, bearing pendant amine functionality. Functionalisation of the photo-switchable scaffolds with squaramide hydrogen bond donors enabled the preparation of a family of anion receptors, which act as photo-regulated transmembrane chloride transporters in response to green or red light. The subtle effects of chlorine/fluorine substitution,meta/parapositioning of the anion receptors, and the use of more flexible linkers are explored. NMR titration experiments on the structurally diverse photo-switchable receptors reveal cooperative binding of chloride in theZ, but notEisomer, by the two squaramide binding sites. These results are supported by molecular dynamics simulations in explicit solvent and model membranes. We show that this intramolecular anion recognition leads to effective switching of transport activity in lipid bilayer membranes, in which optimalZisomer activity is achieved using a combination of fluorine substitution andpara-methylene spacer units.
Targeting Her2-insYVMA with Covalent Inhibitors - A Focused Compound Screening and Structure-Based Design Approach
Lategahn, Jonas,Hardick, Julia,Grabe, Tobias,Niggenaber, Janina,Jeyakumar, Kirujan,Keul, Marina,Tumbrink, Hannah L.,Becker, Christian,Hodson, Luke,Kirschner, Tonia,Kl?vekorn, Philip,Ketzer, Julia,Baumann, Matthias,Terheyden, Susanne,Unger, Anke,Weisner, J?rn,Müller, Matthias P.,Van Otterlo, Willem A. L.,Bauer, Sebastian,Rauh, Daniel
, p. 11725 - 11755 (2020/11/26)
Mutated or amplified Her2 serves as a driver of non-small cell lung cancer or mediates resistance toward the inhibition of its family member epidermal growth factor receptor with small-molecule inhibitors. To date, small-molecule inhibitors targeting Her2 which can be used in clinical routine are lacking, and therefore, the development of novel inhibitors was undertaken. In this study, the well-established pyrrolopyrimidine scaffold was modified with structural motifs identified from a screening campaign with more than 1600 compounds, which were applied against wild-type Her2 and its mutant variant Her2-A775_G776insYVMA. The resulting inhibitors were designed to covalently target a reactive cysteine in the binding site of Her2 and were further optimized by means of structure-based drug design utilizing a set of obtained complex crystal structures. In addition, the analysis of binding kinetics and absorption, distribution, metabolism, and excretion parameters as well as mass spectrometry experiments and western blot analysis substantiated our approach.
